IMM–4800

N/A

Report date: 2025/01/26 15:27:20

Base Information

Drug NameIMM–4800
Drug Alias NameIMM–4800
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionBTB domain and CNC homolog 1 inhibitors
TargetsBTB domain and CNC homolog 1
Therapy Area/IndicationsAnemia, Sickle Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIMMvention Therapeutix Inc
China Registration ClassN/A

Develop Information

Active CompaniesIMMvention Therapeutix Inc
Inactive CompaniesN/A
Active IndicationsAnemia, Sickle Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A